Thiago Carvalho on Nostr: 'Pluvicto is one of a new generation of so-called “radiopharmaceutical” therapies ...
'Pluvicto is one of a new generation of so-called “radiopharmaceutical” therapies that can help cancer patients live longer, but are expensive to produce due to complex supply chains. The US list price of the drug is about $42,500 a dose, with a treatment cycle of up to six doses, but it is not offered by some European health systems.'
https://www.ft.com/content/1a1910e5-fd95-45f9-b8fd-adc4d7b3c8e7Published at
2024-07-20 07:53:35Event JSON
{
"id": "dcf304537491837bdbe98736d1a336bae73fe7cdb041f0e271e6d301ef8e51ac",
"pubkey": "376d961fc946cb96839a4d257809dc9e6d237e2d0cc158199b8cc5c5771939a6",
"created_at": 1721462015,
"kind": 1,
"tags": [
[
"proxy",
"https://qoto.org/users/cyrilpedia/statuses/112817734619723392",
"activitypub"
]
],
"content": "'Pluvicto is one of a new generation of so-called “radiopharmaceutical” therapies that can help cancer patients live longer, but are expensive to produce due to complex supply chains. The US list price of the drug is about $42,500 a dose, with a treatment cycle of up to six doses, but it is not offered by some European health systems.'\n\nhttps://www.ft.com/content/1a1910e5-fd95-45f9-b8fd-adc4d7b3c8e7",
"sig": "71022f6ca541b80cafe928ec116c4d1064acbdf55343f9f4f3b5d2674c038f1abddf4830eb255642bc0521c0fcb1100029945f0af46737245eba878d23f7272d"
}
